Back to School: How biopharma can reboot drug development. Access exclusive analysis here

REG1 anticoagulation system: Phase Ic data

In a double-blind, placebo-controlled Phase Ic trial in 39 volunteers, RB006

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE